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Abstract 
Background: Excessive ventricular pacing is known to be detrimental. The purpose of this study was to assess ventricular pacing in the 
setting of an institutional improvement program in order to decrease unnecessary pacing.
Method: This cross-sectional single-center study performed in a university hospital assessed 80 consecutive patients attending for a 
cardiac electronic device (pacemaker or cardioverter defibrillator) check. Forty percent of ventricular pacing was set as the cutoff level 
beyond which pacing was considered excessive.
Results: Three patients were excluded. Forty-six (59.7%) patients (group 1) had more than 40% ventricular pacing and 31 (40.3%) 
patients (group 2) showed ventricular pacing less than 41%. In group 1, corrective action was successful in 27 (58.7%) patients, but 
19 (41.3%) continued to have ventricular pacing over 40% and were discussed accordingly. An improvement program was established 
at the institution in order to decrease unnecessary ventricular pacing.
Conclusion: Unnecessary ventricular pacing was encountered in many of the patients in this study, corrective actions were performed, 
and an institutional improvement project was set up as a consequence.
Keywords: pacing percentage, physiological pacing, right ventricular pacing, institutional programKossaify et al
80  Clinical Medicine Insights: Cardiology 2012:6
Introduction
Before 1970, ventricular pacing aimed to provide a 
rate backup and simply had a life-saving purpose. 
In late 1970s and beginning of the 1980s, the term 
“physiological pacing” was applied for dual cham-
ber pacers because they preserve the atrioventricu-
lar sequence.1 Until the beginning of the 2000s, the 
terms  “physiological  pacemaker”  and  “physiologi-
cal pacing” were usually applied simply to designate 
dual  chamber  pacers.2  Since  then,  cardiac  pacing 
technology has become increasingly more sophisti-
cated and there has been a trend towards implanting 
pacemakers not only for life-threatening bradycardia 
but also to improve hemodynamics and to prevent 
some  supraventricular  arrhythmias.  Nowadays,  the 
term “physiological pacing” implies preserving and 
restoring a “normal” electrophysiological activation 
pattern of the heart,3 ie, up-to-down atrial activation, 
less interatrial desynchronization, physiological rate-
adaptive  function,  atrioventricular  synchronization, 
intrinsic right ventricular activation with less right 
ventricular pacing, and avoidance of right ventricular 
apical pacing.3,4 The DAVID (Dual Chamber and VVI 
Implantable Defibrillator) trial5 found that ventricular 
pacing at more than 40% increased heart failure and 
mortality rates in a population of patients having an 
ejection fraction less than 40% and with no conven-
tional indication for a pacemaker. The objective of 
this study was to assess the percentage of ventricular 
pacing in the setting of a self-assessment institutional 
program  and  to  devise  a  subsequent  improvement 
program for the institution in order to decrease unnec-
essary ventricular pacing.
Materials and Methods
This was a cross-sectional study in the setting of an 
institutional university hospital improvement program. 
Eighty  consecutive  patients  (61%  male,  mean  age 
66.01 ± 11.8 years) were enrolled between June and 
December 2010. The inclusion criterion was consulta-
tion for regular device follow-up, whether for a pace-
maker or internal defibrillator cardioverter. Patients 
who  had  had  their  devices  implanted  for  less  than 
30 days and patients with cardiac resynchronization 
therapy devices were excluded, along with patients for 
whom ventricular pacing percentage was not assess-
able with the programmer (old devices or devices with 
a fully depleted battery). Patient characteristics and 
other data were collected from patient records along 
with data taken during the device follow-up session 
assigned to the study. All patients signed a written 
informed consent form to participate in this study. The 
study protocol was approved by the ethics committee 
at our institution and conformed to the ethical prin-
ciples for medical research involving human subjects 
outlined in the Helsinki Declaration.
Designations and definition
Ventricular pacing was considered excessive if the 
pacing  percentage  as  assessed  during  the  device 
follow-up session was more than 40%.5 Ventricular 
pacing dependency was considered present when the 
underlying rhythm required high ventricular pacing 
(relative pacing dependency) or permanent ventricu-
lar pacing (absolute pacing dependency). Conditions 
explaining  relative  ventricular  pacing  dependency 
were cases of first degree atrioventricular block with 
a very long PR interval (.300 msec) requiring ven-
tricular pacing to improve hemodynamics and/or for 
a  better  quality  of  life.  Pacemaker  syndrome  was 
defined as signs and symptoms induced by right ven-
tricular pacing and most often related to the loss of 
atrioventricular synchrony.6 Ventricular pacing bur-
den was defined as the interactive consequence of 
two parameters, ie, duration since device implanta-
tion and ventricular pacing percentage.
Device check session
Medical history was taken initially with assessment 
of  types  of  medications,  followed  by  recording  of 
an electrocardiogram for all patients prior to device 
  follow-up. The device follow-up session took place 
in a dedicated room with three-channel electrocardio-
graphic monitoring. Basic parameters were assessed 
(basic programmed rate, impedances, battery status, 
threshold,  sensitivity,  and  underlying  rhythm),  and 
the ventricular pacing percentage was then reported.
Corrective actions
When feasible, corrective actions started during the 
device  follow-up  session  and  consisted  of  device 
reprogramming in order to decrease unnecessary ven-
tricular pacing as much as possible. Other potentially 
corrective actions to decrease ventricular pacing per-
centage consisted of drug therapy adjustment, espe-
cially drugs that may affect sinus node automatism Assessment of ventricular pacing
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and/or atrioventricular conduction (ie, beta-  blockers, 
calcium  channel  blockers).  We  also  activated  a 
c  omputer-based program with an alert notice in order 
to track patients for regular consultation and device 
  follow-up. At the end of this study, a pacer form appli-
cation was created to be supervised by a committee 
that must validate the pacing indication for every new 
patient. This committee consists of three cardiolo-
gists, including at least one electrophysiologist. The 
committee also has the task of recommending which 
type of device is better to implant (ie, single or dual) 
and which technique to use (ie, right ventricular septal 
versus right ventricular apical). Finally, the commit-
tee prohibited company technicians from performing 
device follow-up in the institution unless supervised 
by an electrophysiologist.
Statistical analysis
SPSS version 16.0 (SPSS Inc., Chicago, IL) was used 
for the statistical analysis. Continuous variables were 
expressed as the mean ± standard deviation and cate-
gorical variables were expressed as an absolute num-
ber and percentage. Categorical data were compared 
via the Chi-square test and continuous variable via 
the Student’s t-test. Variables found to have signifi-
cant differences in univariate analysis were evaluated 
for multicollinearity and then enrolled into multivari-
able  logistic  regression  analysis  (stepwise  forward 
logistic regression). A P value ,0.05 was considered 
to be statistically significant.
Results
Of  the  80  patients  enrolled,  77  patients  of  mean 
age 66.01 (range 18–84) years completed the study 
and three were excluded. Of the 77 studied patients 
(Table 1), 31 had ischemic cardiomyopathy, 32 had 
irregular device follow-up, 14 had absolute ventricu-
lar pacing dependency and five had relative ventricular 
pacing dependency, 67 were in sinus rhythm, 45 had 
dual  chamber  pacers,  and  32  patients  had  single 
chamber pacers. Seven patients were found to be left 
with nominal settings.
Forty-six (59.7%) patients had a ventricular pacing 
percentage . 40% (group 1) and 31 (40.3%) had a 
ventricular pacing percentage , 41% (group 2). Initial 
corrective actions when feasible consisted of repro-
gramming devices in order to decrease ventricular pac-
ing; among the 46 patients in group 1, 27 (58.7%) had 
their devices reprogrammed and 19 (41.3%) had their 
devices kept with the same settings due to ventricular 
pacing dependency, whether absolute or relative.
Thirteen variables were analyzed (Table 1) for their 
potential  impact  on  ventricular  pacing    percentage. 
Irregular  device  follow-up,  dual  chamber  devices, 
and ventricular pacing dependency were more prev-
alent  in  the  subgroup  of  patients  with  a  ventricu-
lar pacing   percentage . 40%. Beta-blocker therapy 
and sinus node dysfunction were more prevalent in 
the  subgroup  of  patients  with  a  ventricular  pacing 
  percentage , 41%. Other parameters did not differ 
significantly between the two subgroups.
Table 1. Thirteen variables analyzed for their correlation with ventricular pacing percentage.
patients (n = 77) Vpp . 40% 
59.7% (n = 46)
Vpp , 41% 
40.3% (n = 31)
P value
Age (mean ± SD) 67.15 ± 12.38 64.23 ± 10.74 0.293
Male gender 25 (54.3%) 22 (70.9%) 0.077
Irregular device follow-up 24 (52.1%) 8 (25.8%) 0.034*
Time int-S- L6Y 34 (73.9%) 20 (64.5%) 0.596
Dual chamber 32 (69.5%) 13 (41.9%) 0.032*
relevance of pacing indication 44 (95.6%) 25 (80.6%) 0.149
electrophysiologist operator 33 (71.7%) 23 (74.1%) 0.535
AV search algor 6 (13.04%) 6 (19.3%) 0.393
Sinus rhythm 41 (89.1%) 26 (83.8%) 0.942
VPD 14 (30.4%) 0 (0%) 0.001*
Ischemic cardiomyopathy 15 (32.6%) 16 (51.6%) 0.062
Beta-blocker therapy 23 (50%) 22 (70.9%) 0.034*
Sinus node dysfunction 21 (45.6%) 22 (70.9%) 0.014*
note: *P , 0.05, statistically significant.
Abbreviations: Time int-S- L6Y, time interval since implantation less than 6 years; AV search algor, devices equipped with atrioventricular search 
algorithm; SD, standard deviation; VPD, ventricular pacing dependency.Kossaify et al
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Variables with a P value , 0.05 were enrolled into 
multivariate stepwise logistic regression analysis in 
order to evaluate their predictive value for ventric-
ular  pacing  percentage.  This  analysis  showed  that 
only three variables (irregular device follow-up, dual 
chamber  type,  and  ventricular  pacing  dependency) 
were independent predictors of a ventricular pacing 
percentage . 40% (P , 0.05, Table 2).
New York Heart Association (NYHA) class distri-
bution (Table 3) was reported during device follow-up. 
The heterogeneity of the population for duration of 
implantation and ventricular pacing percentage led 
to different ventricular pacing burdens, and NYHA 
class is considered a consequence of ventricular pac-
ing burden and not causative of ventricular pacing 
percentage. For this reason, the influence of NYHA 
class  distribution  on  ventricular  pacing  percentage 
was not included in the statistical analysis.
The study population included 32 single   chamber 
devices and 45 dual chamber devices.   Pacing types 
and  their  parameters  are  presented  in  Table  4.
Of  the  46  patients  with  a  ventricular  pacing 
  percentage . 40%, 27 had device-based correction to 
reduce their pacing percentage. Among these, eight 
had single chamber devices and 19 had dual chamber 
devices; 13 had their atrioventricular delay manually 
readjusted and six had the automatic atrioventricular 
search algorithm activated in order to enhance their 
intrinsic ventricular activation.
Regarding pharmacological intervention, 23 patients 
in the subgroup with a ventricular pacing percentage   
. 40% were taking beta-blockers.   Nevertheless, beta-
blockers were not found to have a statistically signifi-
cant impact on ventricular pacing percentage, and no 
changes were made accordingly. Further, in the sub-
group of patients with a ventricular pacing   percentage   
. 40%, there were four patients taking verapamil for 
hypertension  which  was  replaced  with  amlodipine. 
This parameter (calcium channel therapy) in a small 
number of patients (n = 4) was not considered powerful 
enough to include in statistical analysis.
Discussion
The rationale for physiological pacing is to restore the 
normal electrophysiology of the heart and in particular 
to preserve a normal activation pattern of the ventri-
cles as much as possible. Accordingly, the pacing pro-
cess should be as “physiological” as possible. Right 
ventricular pacing is known to be deleterious,4,5 with 
many  detrimental  consequences,  related  mainly  to 
atrioventricular and intraventricular dyssynchrony.7,8 
Therefore, ventricular pacing should be avoided and, 
in theory, the least possible is desirable. Accordingly, 
the pacing practice in every institution should aim to 
decrease unnecessary ventricular pacing. A compre-
hensive project for controlling parameters that may 
influence ventricular pacing must be set up for this 
purpose.
Atrioventricular search algorithms are efficient for 
enhancing intrinsic ventricular activation. The find-
ing in this study that devices equipped with these 
algorithms had no significant impact on ventricular 
pacing percentage is not pertinent. The main explana-
tion is that only 12 patients had devices equipped with 
these algorithms, and we also found that these algo-
rithms were not activated in all patients, with many 
of the study patients found to have nominal settings 
while others had device follow-up performed only by 
company technicians.
In this study, ventricular pacing dependency was 
found to be a major determinant of a high ventricular 
pacing percentage (.40%, P = 0.001) and this is a 
logical finding. Of note, this group of patients are rec-
ommended to have their ventricular lead implanted 
in the right ventricular septum or right ventricular 
outflow tract.3,4 Irregular device follow-up was also 
found to be a major determinant (P = 0.034) of a 
high  ventricular  pacing  percentage;  regular  device 
Table 2. Correlation of factors in multivariable regression analysis.
Variables OR 95% cI P value
Lower limit Upper limit
Irregular follow-up 3.583 1.06 12.11 0.031
Dual chamber type 4.3 1.345 14.043 0.009
VPD ,0.00 0.00 ,0.0001
Abbreviations: CI, confidence interval; OR, odds ratio; VPD, ventricular pacing dependency.Assessment of ventricular pacing
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follow-up is crucial for adapting pacer parameters to 
the evolving condition of the patient, as well as reg-
ular consultation to check for medications that may 
interfere with atrioventricular conduction. Irregular 
device follow-up may lead to underdetection of those 
patients left with nominal settings with a subsequent 
risk  of  a  high  ventricular  pacing  percentage.  This 
phenomenon was encountered in seven patients in 
the study population. The influence of company tech-
nicians was predominant, and programming done by 
them was not always adapted to decrease the ventric-
ular pacing percentage, so regular device follow-up 
should be done by an electrophysiologist to avoid 
potential misprogramming.
Dual  chamber  pacers  were  more  prevalent  in 
the subgroup of patients with a ventricular pacing 
  percentage . 40% (P = 0.032) and this finding is con-
sistent with the results of the DAVID trial.5 This may 
be explained by potential misprogramming or non-
programming of the dual pacers (kept with nominal 
atrioventricular delay).
The  pacing  indication  is  critical  for  decreasing 
ventricular pacing, and the best method to avoid ven-
tricular pacing is to avoid pacer implantation if it is 
not justified. In this study, we found eight patients 
without  any  evidence-based  indication  for  pacing. 
For this reason, we started to implement the pacer 
form application in order to adjust pacing indications 
to  guidelines,  whereby  the  pacer  form  application 
council has to validate the pacing indication, and rec-
ommend the type of device and technique of implan-
tation according to the particular clinical condition 
of the patient. Finally, we think that company tech-
nicians do not necessarily have enough expertise to 
perform device follow-up and should be supervised 
by an electrophysiologist.9
Corrective  action  during  device  follow-up  con-
sisted  of  reprogramming  parameters  in  order  to 
enhance intrinsic ventricular activation. For patients 
with a VVI(R) pacemaker, whether in sinus rhythm 
or in atrial fibrillation, we decreased the programmed 
basic rate in order to enhance intrinsic patient rhythm 
whenever this was feasible, and we also programmed 
a night rate “ON” and rate hysteresis “ON” on a case 
by case basis. For patients in sinus rhythm with a 
VVI(R) pacer and for whom the above maneuver was 
not sufficient to enhance intrinsic ventricular activa-
tion, a suggestion note was made in the patient records 
to upgrade to a dual chamber device.
For  patients  with  dual  chamber  devices,  ie, 
VDD  or  DDD(R),  according  to  their  underlying 
  AVatrioventricular  conduction  status,  we  observed 
intrinsic ventricular activation by reprogramming the 
atrioventricular  delay  and/or  activating  algorithms 
that  enhance  intrinsic  ventricular  activation  (when 
the  devices  were  equipped  with  these  algorithms). 
For patients with ventricular pacing dependency and 
for whom ventricular pacing was necessary, we made 
a suggestion in the patient record to consider septal 
pacing4 or even cardiac resynchronization therapy10 
on a case by case basis, and if the patient’s condition 
was expected to improve with the suggested upgrad-
ing technique. Also, we activated a computer-based 
program to be implemented in order to track patients 
and enhance regular device follow-up.
Andersen et al11 showed a lower incidence of atrial 
fibrillation, less heart failure, and higher survival in 
patients  with  sinus  node  dysfunction  treated  with 
atrial  pacing  (AAI)  devices  compared  with  those 
treated with ventricular (VVI) devices. Of note, all 
patients had sinus node dysfunction and atrial-based 
pacing devices were in AAI mode, so the ventricu-
lar  pacing  percentage  was  absolutely  0%  in  this 
subgroup.  Accordingly,  we  hypothesize  that  these 
Table 4. Distribution of device types and parameters in the 
two subgroups of patients (VP , 41% and VP . 40%).
Total patients  
(n = 77)
Vp , 41%  
(n = 31)
Vp . 40%   
(n = 46)
Single chamber  
devices (n = 32) 
27 PM (VVIr), 5 ICD
18 14
Dual chamber devices  
(n = 45) 
30 DDD, 8 VDD, 7 ICD
13 32
Abbreviations: ICD, intracardiac device; PM, pacemaker; VP, ventricular 
pacing.
Table  3.  Distribution  of  different  nYhA  classes  in  both 
subgroups of the study population.
nYHA Vp , 41% (n = 31) Vp . 40% (n = 46)
I 15 23
II 11 11
III 4 9
IV 1 3
Abbreviations: nYhA, new York heart Association; VP, ventricular pacing.Kossaify et al
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benefits were mainly related to the absence of right 
ventricular pacing.
Kerr et al12 showed no difference in cardiovascular 
mortality between DDD and VVI groups. The study 
population included 42% of patients with sinus node 
dysfunction. In this study, there was no mention of 
ventricular pacing percentage in the group presumed 
to be “physiologically” paced (DDD subgroup) and, 
accordingly, we hypothesize that the absence of a dif-
ference regarding cardiovascular outcome could well 
be related to the detrimental effects of right ventricu-
lar pacing in the DDD subgroup.
The UKPACE study13 found that the pacing mode 
(VVI versus DDD) did not affect the incidence of 
cardiovascular  events;  ventricular  pacing  percent-
age was not mentioned in this study, but we expect 
that it was significantly high given that the initial 
indication  was  high-grade  atrioventricular  block. 
  Accordingly,  we  hypothesize  that  the  lack  of  dif-
ference in outcome could well be related to a high 
ventricular  pacing  percentage  in  the  DDD  group. 
In MOST (Mode Selection Trial),14 pacemaker syn-
drome developed in nearly 20% of the VVIR-paced 
patients and the authors concluded that avoiding ven-
tricular pacing is helpful to decrease the occurrence 
of pacemaker syndrome. The ventricular pacing per-
centage was not mentioned in the above presented 
studies,  probably  because  state-of-the-art  device 
technology at that time was not developed enough to 
assess this parameter.
For non-dependent patients, we advocate the use of 
devices equipped with algorithms to enhance intrin-
sic right ventricular activation.15,16 For patients with 
ventricular  pacing  dependency,  septal  (or  outflow 
tract) pacing is proven to be efficient,4 also cardiac 
resynchronization therapy can be evoked in selected 
patients with mild to moderate heart failure10 and has 
proven to be beneficial and cost-effective. As a result 
of decreasing ventricular pacing, there is less risk of 
detrimental effects,16–20 including ventricular remod-
eling and pacing-induced cardiomyopathy.
conclusion
Right  ventricular  pacing  is  deleterious  and  every 
effort should be made to decrease it. Many factors 
must be taken into account in the pacing process in 
order for pacing to be as physiological as possible. 
In this study, 46 (59.7%) patients had a ventricular 
pacing percentage . 40%, and 27 (35%) patients had 
their devices reprogrammed in order to decrease ven-
tricular pacing. Irregular device follow-up, ventricu-
lar pacing dependency, and dual chamber pacers were 
found to be independent predictors of a ventricular 
pacing percentage over 40%. An improvement pro-
gram regarding the pacing process was set accord-
ingly in our institution.
Limitations
The  study  was  monocentric  and  cross-sectional, 
and the study population was limited to 80 patients. 
In  the  group  of  patients  with  a  ventricular  pacing 
  percentage . 40%, this percentage was decreased with 
reprogramming when feasible according to the meth-
ods listed above, but no subsequent device   follow-up 
was included in this study to assess whether the ven-
tricular pacing percentage became less than 41% in 
this group of patients. Due to the limited sample size, 
study  design  (cross-sectional  and  not  prospective), 
and heterogeneity of the patient population, especially 
regarding hemodynamic status, no analysis to assess 
the hemodynamic consequences of ventricular pacing 
percentage was performed. Further, no assessment of 
potential hemodynamic improvement was performed 
after  decreasing  the  ventricular  pacing  percentage. 
Assessment  of  ventricular  pacing  percentage  only 
was set as the main objective, and subsequently the 
improvement program aimed to decrease the ventric-
ular pacing percentage.
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